champ recherche

 

logo Soc Nephrologie
commission transplantation
centre de référence
Centre de référence SNI

Les publications

 

Immunopathogenesis of idiopathic nephrotic syndrome.

Zhang SY, Audard V, Fan Q, Pawlak A, Lang P, Sahali D.

Contrib Nephrol. 2011;169:94-106.

 

Molecular mechanisms in nephrotic syndrome: role of c-mip in podocyte dysfunctions.

Zhang SY, Audard V, Lang P, Sahali D.

Med Sci (Paris). 2010 Jun-Jul;26(6-7):592-6.

 

c-mip impairs podocyte proximal signaling and induces heavy proteinuria.

Zhang SY, Kamal M, Dahan K, Pawlak A, Ory V, Desvaux D, Audard V, Candelier M,

BenMohamed F, Matignon M, Christov C, Decrouy X, Bernard V, Mangiapan G, Lang P,

Guellaën G, Ronco P, Sahali D.

Sci Signal. 2010 May 18;3(122):ra39.

 

Occurrence of minimal change nephrotic syndrome in classical Hodgkin lymphoma is closely related to the induction of c-mip in Hodgkin-Reed Sternberg cells and podocytes.

Audard V, Zhang SY, Copie-Bergman C, Rucker-Martin C, Ory V, Candelier M, Baia M, Lang P, Pawlak A, Sahali D.

Blood. 2010 May 6;115(18):3756-62

 

C-mip interacts with the p85 subunit of PI3 kinase and exerts a dual effect on ERK signaling via the recruitment of Dip1 and DAP kinase.

Kamal M, Pawlak A, BenMohamed F, Valanciuté A, Dahan K, Candelier M, Lang P, Guellaën G, Sahali D.

FEBS Lett. 2010 Feb 5;584(3):500-6

 

Recent advances in the pathophysiology of idiopathic nephrotic syndrome.

Audard V, Ory V, Zhang SY, Candelier M, Pawlak A, Lang P, Sahali D.
Arch Pediatr. 2009 Jun;16(6):793-5.

 

Potential role of soluble ST2 protein in idiopathic nephrotic syndrome recurrence following kidney transplantation.

Bruneau S, Le Berre L, Hervé C, Valanciuté A, Kamal M, Naulet J, Tesson L, Foucher Y, Soulillou JP, Sahali D, Dantal J.

 

C-mip interacts physically with RelA and inhibits nuclear factor kappa B activity.

Kamal M, Valanciute A, Dahan K, Ory V, Pawlak A, Lang P, Guellaen G, Sahali D.
Mol Immunol. 2009 Feb;46(5):991-8.

 

Minimal change nephrotic syndrome : new insights into disease pathogenesis.

Audard V, Lang P, Sahali D.

Med Sci (Paris). 2008 Oct;24(10):853-8.

 

Unexpected efficacy of rituximab in multirelapsing minimal change nephrotic syndrome in the adult: first case report and pathophysiological considerations.

François H, Daugas E, Bensman A, Ronco P.

Am J Kidney Dis. 2007 Jan;49(1):158-61.

 

Minimal change nephrotic syndrome and classical Hodgkin's lymphoma: report of 21 cases and review of the literature.

Audard V, Larousserie F, Grimbert P, Abtahi M, Sotto JJ, Delmer A, Boue F, Nochy D, Brousse N, Delarue R, Remy P, Ronco P, Sahali D, Lang P, Hermine O.

Kidney Int. 2006 Jun;69(12):2251-60.

 

Long-term outcome of children with steroid-sensitive idiopathic nephrotic syndrome.

Niaudet P.

Clin J Am Soc Nephrol. 2009 Oct;4(10):1547-8.

 

Recurrence of nephrotic syndrome after transplantation in a mixed population of children and adults: course of glomerular lesions and value of the Columbia classification of histological variants of focal and segmental glomerulosclerosis (FSGS).

Canaud G, Dion D, Zuber J, Gubler MC, Sberro R, Thervet E, Snanoudj R, Charbit M, Salomon R, Martinez F, Legendre C, Noel LH, Niaudet P.

Nephrol Dial Transplant. 2010 Apr;25(4):1321-8.

 

Induction of T regulatory cells attenuates idiopathic nephrotic syndrome.

Le Berre L, Bruneau S, Naulet J, Renaudin K, Buzelin F, Usal C, Smit H, Condamine T, Soulillou JP, Dantal J.

J Am Soc Nephrol. 2009 Jan;20(1):57-67.

 

 

back
top
 
OK
effacer
plus
OK
effacer
plus
OK
effacer
plus
Sitemap